Home/Filings/4/0001764013-25-000045
4//SEC Filing

Hughes Douglas J. 4

Accession 0001764013-25-000045

CIK 0001764013other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:43 PM ET

Size

7.3 KB

Accession

0001764013-25-000045

Insider Transaction Report

Form 4
Period: 2025-04-01
Transactions
  • Award

    Common Stock

    2025-04-01+16,188135,773 total
  • Award

    Stock Option (right to buy)

    2025-04-01+7,6007,600 total
    Exercise: $15.20Exp: 2035-04-01Common Stock (7,600 underlying)
Footnotes (2)
  • [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
  • [F2]The shares underlying the options will vest on April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date.

Issuer

Immunovant, Inc.

CIK 0001764013

Entity typeother

Related Parties

1
  • filerCIK 0001710863

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:43 PM ET
Size
7.3 KB